Infant feeding and the risk of type 1 diabetes

American Journal of Clinical Nutrition

Volumn 91, Issue 5, 2010, Pages

  Knip, Mikael ^a,c   Virtanen, Suvi M ^b,c,d   Åkerblom, Hans K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; ALPHA TOCOPHEROL; COLECALCIFEROL; PROTEIN; VITAMIN D;

AUTOIMMUNITY; BREAST FEEDING; CHILD GROWTH; CULTURAL FACTOR; DIET; EPIGENETICS; EPIGENOMICS; FOOD; GENOMICS; GEOGRAPHY; GROWTH ACCELERATION; HUMAN; INFANCY; INFANT FEEDING; INFANT NUTRITION; INSULIN DEPENDENT DIABETES MELLITUS; INTERVENTION STUDY; METABOLOMICS; NONHUMAN; OBSERVATIONAL STUDY; PANCREAS ISLET BETA CELL; PILOT STUDY; REVIEW; RISK FACTOR; VITAMIN SUPPLEMENTATION;

BREAST FEEDING; CELL MEMBRANE PERMEABILITY; DEVELOPED COUNTRIES; DIABETES MELLITUS, TYPE 1; DIETARY SUPPLEMENTS; FEMALE; FINLAND; HUMANS; INCIDENCE; INFANT; INFANT FOOD; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INSULIN-SECRETING CELLS; INTESTINAL ABSORPTION; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RICKETS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77951965439     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2010.28701C     Document Type: Review

References (65)

1. Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Åkerblom HK. Environmental triggers and determinants of β-cell autoimmunity and type 1 diabetes. Diabetes 2005;54:S125-36.
2. Ziegler A-G, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999;48:460-468 (Pubitemid 29106857)
3. Kimpimäki T, Kupila A, Hämäläinen A-M, et al. The first signs of β-cell autoimmunity appear in infancy in genetically susceptible children from the general population: The Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab 2001;86:4782-4788
4. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371: 1777-1782 (Pubitemid 351697953)
5. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-2033
6. Virtanen SM, Knip M. Nutritional risk predictors of β-cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr 2003;78:1053-1067 (Pubitemid 40003749)
7. Gerstein HC. Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature. Diabetes Care 1994;17:13-19
8. Norris JM, Barriga K, Klingensmith G, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003;290: 1713-1720 (Pubitemid 37430621)
9. Ziegler A-G, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003;290:1721-1728 (Pubitemid 37430622)
10. Virtanen SM, Kenward MG, Erkkola M, et al. Age at introduction of new foods and advanced beta-cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 2006;49: 1512-1521
11. Kimpimäki T, Erkkola M, Korhonen S, et al. Short exclusive breast-feeding predisposes young children with increased genetic risk of type 1 diabetes to progressive beta-cell autoimmunity. Diabetologia 2001;44: 63-69
12. Holmberg H, Wahlberg J, Vaarala O, Ludvigsson J. the ABIS study group. Short duration of breast-feeding as a risk factor for β-cell auto-antibodies in 5-year-old children from the general population. Br J Nutr 2007;97:111-116
13. Virtanen SM, Räsänen L, Aro A, et al. Infant feeding in Finnish children <7 yr of age with newly diagnosed IDDM. Diabetes Care 1991;14: 415-417
14. Kostraba JN, Cruickshanks KJ, Lawler-Heavner J, et al. Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes 1993;42:288-295
15. Virtanen SM, Räsänen L, Ylönen K, et al. Early introduction of dairy products associated with increased risk of IDDM in Finnish children. Diabetes 1993;42:1786-1790
16. Wadsworth EJK, Shield JPH, Hunt LP, Baum JD. A case-control study of environmental factors associated with diabetes in the under 5s. Diabet Med 1997;14:390-396
17. The EURODIAB Substudy 2 study group. Rapid early growth is associated with increased risk of childhood type 1 diabetes in various European populations. Diabetes Care 2002;25:1755-1760
18. Hyppönen E, Kenward MG, Virtanen SM, et al. Infant feeding, early weight gain and risk of type 1 diabetes. Diabetes Care 1999;22:1961-1965
19. Åkerblom HK, Virtanen SM, Ilonen J, et al. Dietary manipulation of beta-cell autoimmunity in infants at increased risk for type 1 diabetes. Diabetologia 2005;48:829-837
20. Stene LC, Joner G; Norwegian Childhood Diabetes Study Group. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 2003;78:1128-1134
21. Stene LC, Thorsby PM, Berg JP, Rønningen KS, Joner G; Norwegian Childhood Diabetes Study Group. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism, cod liver oil and risk of type 1 diabetes. Pediatr Diabetes 2008;9:40-45
22. Norris JM, Yin X, Lamb MM, et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 2007;298:1420-1428
23. Chase HP, Lescheck E, Rafkin-Mervis L, et al. Nutritional intervention to prevent (NIP) type 1 diabetes: a pilot trial. ICAN: Infant, Child, & Adolescent Nutrition 2009;1:98-107.
24. The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk of type I (insulin-dependent) diabetes mellitus. Diabetologia 1999;42:51-54
25. Hyppönen E, Läärä E, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth cohort study. Lancet 2001;358: 1500-1504
26. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008;93:512-517
27. Wicklow BA, Taback SP. Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk. Ann N Y Acad Sci 2006;1079:310-312
28. 3 on residual β-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 2009;25:411-416
29. Räsänen M, Kronberg-Kippilä C, Ahonen S, et al. Intake of vitamin D by Finnish children aged 3 months to 3 years in relation to socio-demographic factors. Eur J Clin Nutr 2006;60:1317-1322
30. Kondrashova A, Reunanen A, Romanov A, et al. A sixfold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med 2005;37:67-72.
31. Viskari H, Kondrashova A, Koskela P, Knip M, Hyöty H. Circulating vitamin D concentrations in two neighboring populations with markedly different incidence of type 1 diabetes. Diabetes Care 2006;29:1458-1459
32. Beales PE, Williams AJ, Albertini MC, Pozzilli P. Vitamin E delays diabetes onset in the non-obese diabetic mouse. Horm Metab Res 1994; 26:450-452
33. Uusitalo L, Nevalainen J, Niinistö S, et al. Serum α- and γ-tocopherol concentrations and risk of advanced beta-cell autoimmunity in children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 2008;51:773-780
34. Harder T, Ropeke K, Diller N, Stechling Y, Dudenhausen JW, Plagemann A. Birth weight, early weight gain and subsequent risk of type 1 diabetes: systemic review and meta-analysis. Am J Epidemiol 2009;169:1428-1436
35. Hyppönen E, Virtanen SM, Kenward MG, Knip M, Åkerblom HK, The Childhood Diabetes in Finland Study Group. Obesity, increased linear growth and risk of type 1 diabetes mellitus in children. Diabetes Care 2000;23:1755-1760
36. Lammi N, Moltchamove E, Blomstedt PA, Tuomilehto J, Eriksson JG, Karvonen M. Childhood BMI trajectories and the risk of developing young adult-onset diabetes. Diabetologia 2009;52:408-414
37. Catassi C, Bonucci A, Coppa GV, Carlucci A, Giorgi PL. Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J Pediatr Gastroenterol Nutr 1995;21:383-386
38. Jenista JA, Powell KR, Menegus MA. Epidemiology of neonatal enterovirus infection. J Pediatr 1984;104:685-690
39. Sadeharju K, Knip M, Virtanen SM, et al. Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics 2007;119: 941-946
40. Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E. Immunological activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003;52:2287-2295
41. Auricchio R, Paparo F, Maglio M, et al. In-vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes 2004;53: 1680-1683
42. Savilahti E, Åkerblom HK, Tainio V-M, Koskimies S. Children with newly diagnosed insulin dependent diabetes mellitus have increased levels of cow's milk antibodies. Diabetes Res 1988;7:137-140
43. Dahlquist G, Savilahti E, Landin-Olsson M. An increased level of antibodies to beta-lactoglobulin is a risk determinant for early-onset type 1 (insulin-dependent) diabetes mellitus independent of islet cell antibodies and early introduction of cow's milk. Diabetologia 1992;35:980-984
44. Saukkonen T, Savilahti E, Vaarala O, et al. Children with newly diagnosed IDDM have increased levels of antibodies to bovine serum albumin but not to ovalbumin. Diabetes Care 1994;17:970-976
45. Luopajärvi K, Savilahti E, Virtanen SM, et al. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatr Diabetes 2008;9:434-441
46. Tiittanen M, Westerholm-Ormio M, Verkasalo M, Savilahti E, Vaarala O. Infiltration of Foxp3 expressing cells in jejunal mucosa in celiac disease but not in type 1 diabetes. Clin Exp Immunol 2008;152: 498-507.
47. Myers MA, Mackay IR, Zimmet PZ. Toxic type 1 diabetes. Rev Endocr Metab Disord 2003;4:225-231
48. Baeke F, van Etten E, Gysemans C, Overbergh L, Mathieu C. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol Aspects Med 2008;29:376-387
49. Hindmarsh PC, Matthews DR, Di Silvio L, Kurz AB, Brook CG. Relation between height velocity and fasting insulin concentrations. Arch Dis Child 1988;63:665-666
50. Vaarala O, Knip M, Paronen J, et al. Cow milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 1999;48:1389-1394
51. Mojibian M, Chakir H, Lefebvre DE, et al. A diabetes-specific HLA-DR restricted proinflammatory T cell response in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes 2009;58: 1789-1796
52. Hettiarachchi KD, Zimmet PZ, Myers MA. Transplacental exposure to bafilomycin disrupts pancreatic islet organogenesis and accelerates diabetes onset in NOD mice. J Autoimmun 2004;22:287-296
53. Virtanen SM, Roivainen M, Andersson MA, et al. In vitro toxicity of cereulide on porcine pancreatic Langerhans islets. Toxicon 2008;51: 1029-1037
54. Guo SW, Magnuson VL, Schiller JJ, Wang X, Wu Y, Ghosh S. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. Am J Epidemiol 2006; 164:711-724
55. Bailey R, Cooper JD, Zeitels L, et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007;56:2616-2621
56. Bland R, Markovic D, Hills CE, et al. Expression of 25-hydroxyvitamin D3-1-alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004;89-90:121-125
57. Asayama K, Kooy NW, Burr IM. Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J Lab Clin Med 1986;107:459-464
58. Rabinovitch A. Free radicals as mediators of pancreatic islet β-cell injury in autoimmune diabetes. J Lab Clin Med 1992;119:455-456
59. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998;55:1139-1149
60. Jiang Q, Christen S, Shigenaga MK, Ames BN. γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001;74:714-722
61. Palmer JP, Helquist S, Spinas GA, et al. Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 1989;38:1211-1216
62. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type 1 and type 2 diabetes. Diabetologia 2001;44:914-922
63. Orešič M, Simell S, Sysi-Aho M, et al. Dysregulation of lipid and amino acid metabolism precedes autoimmunity in children who later progress to type 1 diabetes. J Exp Med 2008;205:2975-2984
64. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009;33:3-11.
65. Junien C. Impact of diets and nutrients/drugs on early epigenetic programming. J Inherit Metab Dis 2006;29:359-365